ACURA PHARMS INC (ACUR) analyst actions
Rating and price-target actions on ACUR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ACUR overview →
No ACUR analyst action events in the measured window.
Nothing matched in the current window — the ACUR overview has every event we measure for this name.
Get an email when ACUR moves on news →Keep exploring
More ACUR: earnings → · SEC filings → · ACUR overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REPLICEL LIFE SCIENCE ORD (REPCF) | 59 | 0.00% | 27% |
| REALM THERAPEUTICS PLC ADS (RLM) | 59 | 0.00% | 41% |
| ONCOBIOLOGICS (ONS) | 58 | 0.00% | 47% |
| BESPOKE EXTRACTS INC (BSPK) | 57 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.